Taigo Kato

Papers

Total Citations

H-Index

About

Taigo Kato is a urologic oncologist whose research centers on improving outcomes for patients with bladder cancer, with a particular focus on surgical recovery and perioperative risk stratification. In his most-cited work, Kato investigated predictive factors for prolonged hospitalization following radical cystectomy, the gold-standard curative treatment for localized bladder cancer. His retrospective study identified that elevated preoperative C-reactive protein (CRP) levels serve as a significant independent predictor of extended hospital stays, even after accounting for patient demographics, surgical variables, and postoperative complications. This finding has direct clinical utility, enabling surgeons to identify high-risk patients preoperatively and implement enhanced recovery protocols or closer monitoring to reduce length of stay. While his citation count is still growing, Kato’s work contributes to the broader movement toward personalized surgical care and value-based oncology. By linking a simple, inexpensive blood biomarker to a major health system outcome, he provides a practical tool for improving both patient experience and resource utilization. His research exemplifies how translational urologic oncology can bridge laboratory markers and real-world surgical decision-making.